Mon, Aug 3, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Supreme Court rules that securities fraud class action plaintiffs are not required to prove materiality of alleged misstatements

Tuesday, March 05, 2013

Bailey McCann, Opalesque New York: The US Supreme Court has issued a new ruling that will have an impact for both investment firms and investors. According to a client alert from law firm Shulte, Roth & Zable, the ruling shows that securities fraud class action plaintiffs are not required to prove the materiality of alleged misstatements as a prerequisite to class certification. The ruling was on the case Amgen Inc. v. Connecticut Retirement Plans and Trust Funds and clarifies Court of Appeals rulings around what plaintiffs had to provide before getting class action status.

The ruling comes after the Connecticut Retirement Plans and Trust Funds brought a securities fraud class action against Amgen Inc. and several of its officers, Connecticut Retirement used the fraud-on-the-market presumption, to bring the class action over what they alleged was stock price inflation on two of Amgen's flagship products. According to attorneys in the alert, "absent the fraud-on-the-market theory, individual reliance issues will typically preclude class certification, making it impossible for plaintiffs to show that common questions predominate over questions affecting only individual members."

Amgen conceded the allegations made by Connecticut Retirement but still said they didn't qualify for a class action becaus......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Other Voices: Same day reporting and the evolving role of fund administrators[more]

    By: Scott Price, Head of Business Development and Client Management for North America, Maitland Ernst & Young’s latest glob

  2. Activist News - Celgene says patent-fighting hedge fund manager wants to short its shares[more]

    From Reuters.com: Celgene Corp, one of the world's largest biotechnology companies, has accused U.S. hedge fund manager Kyle Bass of attempting to profit from his attempts to wipe out several major drug patents through his Coalition for Affordable Drugs. The company asked the U.S. Patent and T

  3. Einhorn's Greenlight Capital hedge fund slumps 6.1 percent in July[more]

    From Reuters/Thefiscaltimes.com: Hedge fund mogul David Einhorn's Greenlight Capital slumped 6.1 percent in July and is now down 9 percent for the year after gold, one of the fund's top holdings, tumbled to five-year lows last week. Greenlight notified clients of its returns late on Friday, ac

  4. Cowen Group, Inc. to acquire Conifer Securities[more]

    Cowen Group, Inc. and Conifer Securities, LLC had announced the signing of a definitive agreement under which Cowen will acquire Conifer Securities, the prime services division of Conifer Financial Services LLC. The transaction, the terms of which have not yet been disclosed, was approved by the boa

  5. Cargill’s Black River Asset to shut down four hedge funds[more]

    Komfie Manalo, Opalesque Asia: Cargill Inc.’s $7.4 billion Black River Asset Management said it was closing four hedge funds with a combined $ 1 billion in assets and start returning investors money over the next several months, various media said. The hedge funds represent 15% of Black River’

 

banner